Award
NIH Reporter #1R01DK149654-01
Targeting Intracellular CD38 to Reduce Ischemia-Reperfusion Injury in Liver Transplantation
Recipient
Ohio State University
Award Amount
$807,563.00
Ceiling
$807,563.00
Awarded
August 24, 2026
Identifier
1R01DK149654-01
The project will study how type III CD38 contributes to liver ischemia-reperfusion injury, develop selective inhibitors, and evaluate their effectiveness in animal models and human liver tissue.
Description
Research award to investigate and develop selective type III CD38 inhibitors to reduce ischemia-reperfusion injury and improve donor liver function in transplantation.